Filing Flows › Aligos Therapeutics (ALGS) › Recalls, complaints & regulation
Aligos Therapeutics (ALGS): clinical trials
Aligos Therapeutics (ALGS) beyond its filings: 2 active clinical trials.
Aligos Therapeutics' latest quarter
Aligos Therapeutics, Q3 2026: revenue $2.8M (+282% year over year), operating margin -773.5%, net loss $21.9M, operating cash flow $1.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Aligos Therapeutics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.